BridgeBio Pharma, Inc. (LSX:A2PLX7) IPO

BridgeBio Pharma, Inc.

IPO

Priced at US$17.00 a share on Jun 26, 2019.

Price
US$17.00 a share
Shares offered
20,500,000 shares of common stock
Offering size
US$348.5 million
Underwriters' option
Up to 3,075,000 more shares
Underwriters
J.P. Morgan, Goldman Sachs & Co. LLC, Jefferies, SVB Leerink, KKR, Piper Jaffray, Mizuho Securities, BMO Capital Markets, Raymond James · In the order on the cover
Shares delivered
On or about Jul 1, 2019

Steps

StepWhen
Draft sent to the SEC in confidenceFeb 14, 2019
Filed publiclyMay 24, 2019
Amended 4 timesNewest Jun 26, 2019
Shares registered with an exchangeJun 26, 2019
Declared effective by the SECJun 26, 2019
Final prospectus, with the priceJun 28, 2019

From the cover of the final prospectus (424B4) filed Jun 28, 2019